CD140a, Human (Tovetumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD140a, Human (Tovetumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD140a, Human (Tovetumab biosimilar)
CloneTovetumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIP, IF, FuncS, FCM, Neut, ELISA, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD140a Recombinant Antibody (Tovetumab). Tovetumab is an anti-PDGFRa monoclonal antibody designed for the treatment of cancer. It was developed by MedImmune, and trialed for use in glioblastoma and non-small cell lung cancer. Development was discontinued in 2013. This drug was developed by MedImmune, LLC.
Immunogenn/a
Other NamesAnti-CD140a Recombinant Antibody, Research Grade Tovetumab, Anti-Human CD140a Recombinant Antibody(Tovetumab), MEDI-575, Antibody Drug Analogues, Monoclonal Antibody, YR1314, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1243266-04-7
Catalog #YR1314
Priceplease inquire
Order / More InfoCD140a, Human (Tovetumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.